DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCorporate Action

Avience Biomedicals Limited — Change in Directors/KMP/SMP/Auditor/RTA

NSE 25 Aug·25 Aug 2026, 7:16 pm

AVIENCE NSE

Avience Biomedicals Limited has announced a change in its key personnel, including directors, key managerial personnel, and statutory auditors. The company has filed a formal notice with stock exchanges to disclose this internal transition.

This update is a routine corporate governance matter and typically signals a shift in leadership or oversight. For investors, it is important to monitor the new appointments to ensure there are no immediate disruptions to the company's strategic direction or operations.

Investors should watch for any detailed disclosures regarding the new appointees' backgrounds and the reasons for the change. This information will help assess if the transition is a standard reshuffle or a significant structural change for the company.